Study on effective optical region in patients with different degree of myopia after Smartsight

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200057076

Enrollment

Unknown

Registered

2022-02-27

Start date

2022-02-21

Completion date

Unknown

Last updated

2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive error

Interventions

Experimental group:Smartsight

Control group:Smile surgery

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 years old or above; 2. Understand and voluntarily sign informed consent; 3. As judged by the investigator, the inclusion criteria were met.

Exclusion criteria

Exclusion criteria: 1. Pregnant or breast-feeding; 2. Low mood or anxiety when unstable; 3. Improper motivation or unreasonable expectations; 4. Collagen vascular, autoimmune, or immune deficiency diseases; 5. Herpes simplex virus infection, such as shingles; 6. Diabetes mellitus; 7. Severe dry eye/Sjogren's syndrome; 8. Severe local infection or allergic disease.

Design outcomes

Primary

Measure	Time frame
Effective optical region;	—

Secondary

Measure	Time frame
Q value;Corneal optical density;Aberration;	—

Countries

China

Contacts

Public ContactLili Guo

Hainan (Boao) International Eye Hospital

453560791@qq.com+86 13736993106

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026